Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Some alopecia treatments might help treat COVID-19, but more research is needed.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Lower LDL-c levels predict higher COVID-19 mortality.

Social media data can help track and predict COVID-19 symptoms and trends.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.